UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock ADMA Nasdaq Global Market ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission fil ...

ADMA Biologics, Inc. (NASDAQ:ADMA) Q2 2022 Earnings Conference Call August 10, 2022 4:30 PM ET Company Participants Skyler Bloom - Senior Director, Business Development and Corporate Strategy Adam Grossman - President and Chief Executive Officer Brian Lenz - EVP, Chief Financial Officer and General Manager, ADMA BioCenters Conference Call Participants Elliot Wilbur - Raymond James Kristen Kluska - Cantor Fitzgerald Operator Good afternoon, and welcome to the ADMA Biologics Second Quarter 2022 Financial Resu ...

ADMA Biologics, Inc. (NASDAQ:ADMA) Q1 2022 Earnings Conference Call May 11, 2022 4:30 PM ET Company Participants Skyler Bloom - Senior Director, Business Development and Corporate Strategy Adam Grossman - President and Chief Executive Officer Brian Lenz - Executive Vice President, Chief Financial Officer and General Manager, ADMA BioCenters Conference Call Participants Elliot Wilbur - Raymond James Kristen Kluska - Cantor Fitzgerald Operator Good afternoon, and welcome to the ADMA Biologics First Quarter 20 ...

ADMA Biologics, Inc. (NASDAQ:ADMA) Q4 2021 Earnings Conference Call March 24, 2022 4:30 PM ET Company Participants Skyler Bloom - Director, Business Development & Corporate Strategy Adam Grossman - President and CEO Brian Lenz - EVP & CFO Conference Call Participants Elliot Wilbur - Raymond James Kristen Kluska - Cantor Fitzgerald Zach Weiner - Jefferies Operator Good afternoon, and welcome to the ADMA Biologics Fourth Quarter and Full Year 2021 Financial Results and Corporate Update Conference Call on Thu ...

ADMA Biologics, Inc. (NASDAQ:ADMA) Q3 2021 Earnings Conference Call November 10, 2021 4:30 PM ET Company Participants Skyler Bloom - Director, IR & Corporate Strategy Adam Grossman - Co-Founder, President, CEO & Director Brian Lenz - EVP & CFO Conference Call Participants Kristen Kluska - Cantor Fitzgerald & Co. Anthony Petrone - Jefferies Elliot Wilbur - Raymond James & Associates Operator Good afternoon, and welcome to the ADMA Biologics Third Quarter 2021 Financial Results and Corporate Update Conference ...

ADMA Biologics, Inc. (NASDAQ:ADMA) Q2 2021 Earnings Conference Call August 11, 2021 4:30 PM ET Company Participants Skyler Bloom - Director of Investor Relations & Corporate Strategy Adam Grossman - President & Chief Executive Officer Brian Lenz - Executive Vice President & Chief Financial Officer Conference Call Participants Anthony Petrone - Jefferies Elliot Wilbur - Raymond James Operator Good afternoon, and welcome to ADMA Biologics Second Quarter 2021 Financial Results and Corporate Update Conference ...